This inventor holds 1 USPTO granted patent and 3 published patent applications and 32 EPO patents. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Pascal Furet
Introduction
Pascal Furet is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various diseases. Although he currently holds no granted patents, his work has the potential to impact medical treatments significantly.
Latest Patent Applications
Pascal Furet's latest patent applications include several innovative compounds and methods. One notable application is for 1H-imidazo[4,5-c]quinolinone compounds, which are used in the treatment of protein and/or lipid kinase dependent diseases. This invention encompasses the use of these compounds in pharmaceutical preparations and methods of treatment for warm-blooded animals, especially humans. Another application involves substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors, aimed at treating inflammatory or obstructive airway diseases and other related disorders.
Conclusion
Pascal Furet's work exemplifies the ongoing innovation in the pharmaceutical industry, focusing on developing new treatments for complex diseases. His contributions, although not yet patented, reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile